California State Teachers Retirement System Trims Stake in NxStage Medical, Inc. (NXTM)

California State Teachers Retirement System cut its stake in shares of NxStage Medical, Inc. (NASDAQ:NXTM) by 25.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 103,218 shares of the medical device company’s stock after selling 35,997 shares during the quarter. California State Teachers Retirement System owned approximately 0.15% of NxStage Medical worth $2,954,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of NXTM. Bank of New York Mellon Corp increased its position in NxStage Medical by 5.2% in the second quarter. Bank of New York Mellon Corp now owns 605,270 shares of the medical device company’s stock worth $16,888,000 after purchasing an additional 29,934 shares during the period. Alliancebernstein L.P. increased its position in NxStage Medical by 50.3% in the third quarter. Alliancebernstein L.P. now owns 222,628 shares of the medical device company’s stock worth $6,209,000 after purchasing an additional 74,490 shares during the period. Janus Henderson Group PLC increased its position in NxStage Medical by 25.5% in the third quarter. Janus Henderson Group PLC now owns 10,505 shares of the medical device company’s stock worth $293,000 after purchasing an additional 2,134 shares during the period. BlackRock Inc. increased its position in NxStage Medical by 0.9% in the third quarter. BlackRock Inc. now owns 5,338,295 shares of the medical device company’s stock worth $148,885,000 after purchasing an additional 48,689 shares during the period. Finally, Trexquant Investment LP acquired a new stake in NxStage Medical in the third quarter worth about $645,000. 80.34% of the stock is currently owned by institutional investors and hedge funds.

A number of analysts recently commented on the company. Zacks Investment Research upgraded NxStage Medical from a “hold” rating to a “buy” rating and set a $32.00 price objective for the company in a research report on Wednesday, January 30th. BidaskClub upgraded NxStage Medical from a “hold” rating to a “buy” rating in a research report on Friday, December 21st.

NxStage Medical stock opened at $30.00 on Tuesday. The stock has a market cap of $2.00 billion, a PE ratio of -136.36 and a beta of 0.25. NxStage Medical, Inc. has a 1 year low of $23.17 and a 1 year high of $30.00.

TRADEMARK VIOLATION WARNING: “California State Teachers Retirement System Trims Stake in NxStage Medical, Inc. (NXTM)” was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://sportsperspectives.com/2019/04/02/california-state-teachers-retirement-system-trims-stake-in-nxstage-medical-inc-nxtm.html.

NxStage Medical Profile

NxStage Medical, Inc, a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting.

Further Reading: Net Margin

Want to see what other hedge funds are holding NXTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NxStage Medical, Inc. (NASDAQ:NXTM).

Institutional Ownership by Quarter for NxStage Medical (NASDAQ:NXTM)

Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.